Takeda Joins International Drug Maker Consortium To Map Proteins
This article was originally published in PharmAsia News
Executive Summary
Takeda Pharmaceutical said it is joining the Structural Genomics Consortium with a contribution of $8 million to help map the structure of human proteins.